Literature DB >> 28666867

Enhancement of TGF-β-induced Smad3 activity by c-Abl-mediated tyrosine phosphorylation of its coactivator SKI-interacting protein (SKIP).

Kazumasa Kuki1, Noritaka Yamaguchi2, Shuto Iwasawa1, Yuki Takakura1, Kazumasa Aoyama1, Ryuzaburo Yuki1, Yuji Nakayama3, Takahisa Kuga3, Yuuki Hashimoto4, Takeshi Tomonaga4, Naoto Yamaguchi5.   

Abstract

c-Abl is a non-receptor-type tyrosine kinase that plays an important role in cell proliferation, migration, apoptosis, and fibrosis. Furthermore, although c-Abl is involved in transforming growth factor-β (TGF-β) signaling, its molecular functions in TGF-β signaling are not fully understood. Here, we found that c-Abl phosphorylates SKI-interacting protein (SKIP), a nuclear cofactor of the transcription factor Smad3. The c-Abl inhibitor imatinib suppressed TGF-β-induced expression of Smad3 targets as well as SKIP/Smad3 interaction. TGF-β-stimulation induced tyrosine phosphorylation of SKIP, and this phosphorylation was suppressed by imatinib. Tyr292, Tyr430, and Tyr433 residues in SKIP were shown to be involved in c-Abl-mediated phosphorylation. Phosphomimetic glutamic acid substitution at Tyr292 in SKIP enhanced, whereas its phospho-dead phenylalanine substitution attenuated TGF-β-induced SKIP/Smad3 interaction. Moreover, the phosphomimetic mutant of SKIP augmented transcriptional activity of Smad3. Taken together, these results suggest that c-Abl phosphorylates SKIP mainly at Tyr292 and promotes SKIP/Smad3 interaction for the full activation of TGF-β/Smad3 signaling.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nuclear cofactor; SKI-interacting protein (SKIP, SNW1, NCoA62); Smad3; Transforming growth factor-β (TGF-β); c-Abl

Mesh:

Substances:

Year:  2017        PMID: 28666867     DOI: 10.1016/j.bbrc.2017.06.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  SNW1, a Novel Transcriptional Regulator of the NF-κB Pathway.

Authors:  Suneer Verma; Paul De Jesus; Sumit K Chanda; Inder M Verma
Journal:  Mol Cell Biol       Date:  2019-01-16       Impact factor: 4.272

2.  Desuppression of TGF-β signaling via nuclear c-Abl-mediated phosphorylation of TIF1γ/TRIM33 at Tyr-524, -610, and -1048.

Authors:  Ryuzaburo Yuki; Takashi Tatewaki; Noritaka Yamaguchi; Kazumasa Aoyama; Takuya Honda; Sho Kubota; Mariko Morii; Ichiro Manabe; Takahisa Kuga; Takeshi Tomonaga; Naoto Yamaguchi
Journal:  Oncogene       Date:  2018-09-03       Impact factor: 9.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.